EraCal Therapeutics AG

Pharmaceuticals · Basel, Basel-Stadt

EraCal Therapeutics AG is a Swiss pharmaceuticals company based in Basel, Canton of Basel-Stadt, listed in the Swiss commercial register since 2018 (UID CHE-419.108.104).

Legal nameEraCal Therapeutics AG
AddressAeschengraben 13, Basel
UID / VATCHE-419.108.104
Legal form · StatusAG · Active · 2018

Board members & signatories

  • Ann Kessler — Präsident des Verwaltungsrates
  • Pauline-Sue Pfirter — Mitglied des Verwaltungsrates
  • Bettina Ernst — Mitglied des Verwaltungsrates

Registered purpose

Der Zweck der Gesellschaft ist die Erforschung inkl. Entdeckung, Entwicklung, Herstellung, Verwertung, der Erwerb, Marketing, Verkauf und Vertrieb von pharmazeutischen Produkten und Verfahren, sowie Technologien zur Entwicklung, Diagnostik und (bio)medizinischer Forschung und Produktion. Die Gesellschaft kann alle kommerziellen, finanziellen und anderen Tätigkeiten ausüben, welche mit dem Zweck de…

🔒 Website🔒 Employees🔒 Revenue estimate

Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026

What EraCal Therapeutics does

OFFERING

EraCal Therapeutics focuses on developing therapies for cardiometabolic diseases. The company has entered into various collaboration and licensing agreements, including a notable deal with Novo Nordisk. Their research includes a differentiated phenotypic strategy to measure food intake and energy expenditure.

Unlock the full analysis →

Similar companies

Find every pharmaceuticals company in Switzerland

Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.

family-owned pharmaceuticals companies with 50+ employees…Search →

Full profiles from CHF 49/month · Cancel anytime